Cargando…
Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM
OBJECTIVE: To quantify the impact of International Classification of Disease 10th Revision Clinical Modification (ICD-10-CM) transition in cancer clinical trials by comparing coding accuracy and data discontinuity in backward ICD-10-CM to ICD-9-CM mapping via two tools, and to develop a standard ICD...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226400/ https://www.ncbi.nlm.nih.gov/pubmed/25452683 http://dx.doi.org/10.4137/CIN.S14032 |
_version_ | 1782343617613922304 |
---|---|
author | Venepalli, Neeta K Shergill, Ardaman Dorestani, Parvaneh Boyd, Andrew D |
author_facet | Venepalli, Neeta K Shergill, Ardaman Dorestani, Parvaneh Boyd, Andrew D |
author_sort | Venepalli, Neeta K |
collection | PubMed |
description | OBJECTIVE: To quantify the impact of International Classification of Disease 10th Revision Clinical Modification (ICD-10-CM) transition in cancer clinical trials by comparing coding accuracy and data discontinuity in backward ICD-10-CM to ICD-9-CM mapping via two tools, and to develop a standard ICD-9-CM and ICD-10-CM bridging methodology for retrospective analyses. BACKGROUND: While the transition to ICD-10-CM has been delayed until October 2015, its impact on cancer-related studies utilizing ICD-9-CM diagnoses has been inadequately explored. MATERIALS AND METHODS: Three high impact journals with broad national and international readerships were reviewed for cancer-related studies utilizing ICD-9-CM diagnoses codes in study design, methods, or results. Forward ICD-9-CM to ICD-10-CM mapping was performing using a translational methodology with the Motif web portal ICD-9-CM conversion tool. Backward mapping from ICD-10-CM to ICD-9-CM was performed using both Centers for Medicare and Medicaid Services (CMS) general equivalence mappings (GEMs) files and the Motif web portal tool. Generated ICD-9-CM codes were compared with the original ICD-9-CM codes to assess data accuracy and discontinuity. RESULTS: While both methods yielded additional ICD-9-CM codes, the CMS GEMs method provided incomplete coverage with 16 of the original ICD-9-CM codes missing, whereas the Motif web portal method provided complete coverage. Of these 16 codes, 12 ICD-9-CM codes were present in 2010 Illinois Medicaid data, and accounted for 0.52% of patient encounters and 0.35% of total Medicaid reimbursements. Extraneous ICD-9-CM codes from both methods (Centers for Medicare and Medicaid Services general equivalent mapping [CMS GEMs, n = 161; Motif web portal, n = 246]) in excess of original ICD-9-CM codes accounted for 2.1% and 2.3% of total patient encounters and 3.4% and 4.1% of total Medicaid reimbursements from the 2010 Illinois Medicare database. DISCUSSION: Longitudinal data analyses post-ICD-10-CM transition will require backward ICD-10-CM to ICD-9-CM coding, and data comparison for accuracy. Researchers must be aware that all methods for backward coding are not comparable in yielding original ICD-9-CM codes. CONCLUSIONS: The mandated delay is an opportunity for organizations to better understand areas of financial risk with regards to data management via backward coding. Our methodology is relevant for all healthcare-related coding data, and can be replicated by organizations as a strategy to mitigate financial risk. |
format | Online Article Text |
id | pubmed-4226400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Libertas Academica |
record_format | MEDLINE/PubMed |
spelling | pubmed-42264002014-12-01 Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM Venepalli, Neeta K Shergill, Ardaman Dorestani, Parvaneh Boyd, Andrew D Cancer Inform Review OBJECTIVE: To quantify the impact of International Classification of Disease 10th Revision Clinical Modification (ICD-10-CM) transition in cancer clinical trials by comparing coding accuracy and data discontinuity in backward ICD-10-CM to ICD-9-CM mapping via two tools, and to develop a standard ICD-9-CM and ICD-10-CM bridging methodology for retrospective analyses. BACKGROUND: While the transition to ICD-10-CM has been delayed until October 2015, its impact on cancer-related studies utilizing ICD-9-CM diagnoses has been inadequately explored. MATERIALS AND METHODS: Three high impact journals with broad national and international readerships were reviewed for cancer-related studies utilizing ICD-9-CM diagnoses codes in study design, methods, or results. Forward ICD-9-CM to ICD-10-CM mapping was performing using a translational methodology with the Motif web portal ICD-9-CM conversion tool. Backward mapping from ICD-10-CM to ICD-9-CM was performed using both Centers for Medicare and Medicaid Services (CMS) general equivalence mappings (GEMs) files and the Motif web portal tool. Generated ICD-9-CM codes were compared with the original ICD-9-CM codes to assess data accuracy and discontinuity. RESULTS: While both methods yielded additional ICD-9-CM codes, the CMS GEMs method provided incomplete coverage with 16 of the original ICD-9-CM codes missing, whereas the Motif web portal method provided complete coverage. Of these 16 codes, 12 ICD-9-CM codes were present in 2010 Illinois Medicaid data, and accounted for 0.52% of patient encounters and 0.35% of total Medicaid reimbursements. Extraneous ICD-9-CM codes from both methods (Centers for Medicare and Medicaid Services general equivalent mapping [CMS GEMs, n = 161; Motif web portal, n = 246]) in excess of original ICD-9-CM codes accounted for 2.1% and 2.3% of total patient encounters and 3.4% and 4.1% of total Medicaid reimbursements from the 2010 Illinois Medicare database. DISCUSSION: Longitudinal data analyses post-ICD-10-CM transition will require backward ICD-10-CM to ICD-9-CM coding, and data comparison for accuracy. Researchers must be aware that all methods for backward coding are not comparable in yielding original ICD-9-CM codes. CONCLUSIONS: The mandated delay is an opportunity for organizations to better understand areas of financial risk with regards to data management via backward coding. Our methodology is relevant for all healthcare-related coding data, and can be replicated by organizations as a strategy to mitigate financial risk. Libertas Academica 2014-11-09 /pmc/articles/PMC4226400/ /pubmed/25452683 http://dx.doi.org/10.4137/CIN.S14032 Text en © 2014 the author(s), publisher and licensee Libertas Academica Ltd. This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 License. |
spellingShingle | Review Venepalli, Neeta K Shergill, Ardaman Dorestani, Parvaneh Boyd, Andrew D Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM |
title | Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM |
title_full | Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM |
title_fullStr | Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM |
title_full_unstemmed | Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM |
title_short | Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM |
title_sort | conducting retrospective ontological clinical trials in icd-9-cm in the age of icd-10-cm |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226400/ https://www.ncbi.nlm.nih.gov/pubmed/25452683 http://dx.doi.org/10.4137/CIN.S14032 |
work_keys_str_mv | AT venepallineetak conductingretrospectiveontologicalclinicaltrialsinicd9cmintheageoficd10cm AT shergillardaman conductingretrospectiveontologicalclinicaltrialsinicd9cmintheageoficd10cm AT dorestaniparvaneh conductingretrospectiveontologicalclinicaltrialsinicd9cmintheageoficd10cm AT boydandrewd conductingretrospectiveontologicalclinicaltrialsinicd9cmintheageoficd10cm |